Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Actuarialon Dec 17, 2020 11:43am
150 Views
Post# 32128385

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Good Old Fashion Tree Shake

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Good Old Fashion Tree ShakeDo you truly understand what is called at most? Without news, it could be up or down for any single day. 5% down is nothing as it could be 5% up the other day. Day traders like you flip the stock for a few dollar profits. Nothing to worry about.
clubhouse19 wrote: You are too funny...that's what i call hyper fantasy thinking and down 5% per day is nothing according to you 
Sounds like you are trying to convince yourself more than anyone else 


Actuarial wrote: Down is kind of gradual (at most 5% in a day) with no news but up would be very steep (so often over 100% in a day) should we hear great news. In a Bio industry, either you hear nothing, or, you hear something big. In ATE case, something big can only be positive as ATE has already passed the most risky PhII.
Doccole wrote:

I agree.  There is something on the horizon.   I view this as a buying opportunity.  I continue to add.  


yesterday was down, but so was volume.  It can bounce up as fast as it can down. 


 




<< Previous
Bullboard Posts
Next >>